These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 10411781)

  • 1. The intrauterine contraceptive device: an often-forgotten and maligned method of contraception.
    Dardano KL; Burkman RT
    Am J Obstet Gynecol; 1999 Jul; 181(1):1-5. PubMed ID: 10411781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine devices and intrauterine systems.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2008; 14(3):197-208. PubMed ID: 18400840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of intrauterine devices in nulliparous women.
    Lohr PA; Lyus R; Prager S
    Contraception; 2017 Jun; 95(6):529-537. PubMed ID: 27591814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability of IUDs is increasing.
    Finger WR; Barr D
    Netw Res Triangle Park N C; 1992 Oct; 13(2):27-30. PubMed ID: 12286082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of intrauterine contraceptive devices, pelvic inflammatory disease, and Chlamydia trachomatis infection.
    Edelman DA
    Am J Obstet Gynecol; 1988 Apr; 158(4):956-9. PubMed ID: 3284365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of emergency contraception options over 1 year.
    Bellows BK; Tak CR; Sanders JN; Turok DK; Schwarz EB
    Am J Obstet Gynecol; 2018 May; 218(5):508.e1-508.e9. PubMed ID: 29409847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
    Bilgehan F; Dilbaz B; Karadag B; Deveci CD
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1426-32. PubMed ID: 26180028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement.
    Turok DK; Eisenberg DL; Teal SB; Keder LM; Creinin MD
    Am J Obstet Gynecol; 2016 Nov; 215(5):599.e1-599.e6. PubMed ID: 27180886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods.
    Bahamondes L; Valeria Bahamondes M; Shulman LP
    Hum Reprod Update; 2015; 21(5):640-51. PubMed ID: 26037216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system.
    Eisenberg DL; Schreiber CA; Turok DK; Teal SB; Westhoff CL; Creinin MD;
    Contraception; 2015 Jul; 92(1):10-6. PubMed ID: 25934164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of levonorgestrel-releasing intrauterine devices in adolescents - own experience.
    Drosdzol-Cop A; Czech IJ; Stojko R; Skrzypulec-Plinta V
    Ginekol Pol; 2020; 91(6):342-345. PubMed ID: 32400883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
    Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
    Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine contraception in nulliparous women: a prospective survey.
    Hall AM; Kutler BA
    J Fam Plann Reprod Health Care; 2016 Jan; 42(1):36-42. PubMed ID: 25854550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age.
    Borgatta L; Buhling KJ; Rybowski S; Roth K; Rosen K
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):372-9. PubMed ID: 27494570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.